CCI imposes Rs 18 cr penalty on Bengal Chemist and Druggist Association
It was alleged that BCDA is inter alia engaged in issuing anti-competitive circulars directing the retailers not to give any discount to the consumers
BS B2B Bureau B2B Connect | New Delhi

In the reference filed by Dr Ghosh, it was alleged that BCDA is inter alia engaged in issuing anti-competitive circulars directing the retailers not to give any discount to the consumers. The CCI after considering the entire material had directed the Director General (DG) to cause an investigation into the matter and to submit a report.
The CCI observed that the activities of BCDA inter alia to direct its members to sell drugs only at their MRP is a palpable anti-competitive conduct which cannot be justified on the ground that most of the members of the BCDA, would be ruined if competitive forces are allowed to operate in the market. The CCI accordingly concluded that the activities of the BCDA are in conflict with the objects of the competition law as they cause restraint of trade, stifle competition and harm the consumers.
Also Read
After giving due consideration on the issue, the CCI decided to impose a penalty on the BCDA and its those office bearers who were directly responsible for running its affairs and play lead role in decision making at 10% and on the executive committee members at 7%, of their respective turnover/income/receipts.
The BCDA has been further directed to file an undertaking within 30 days that the CCI’s directions regarding seize and desist from indulging in anticompetitive practices have been complied with. The amount of penalty imposed was directed to be deposited within 60 of the receipt of the order.
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Mar 15 2014 | 11:39 AM IST

